CSX Corporation
CSX
$46.16
-0.09%
CSX Corporation is a Class I railroad operating primarily in the Eastern United States, providing freight transportation services across a network of over 21,000 miles of track. The company is a dominant player in the North American rail industry, distinguished by its extensive network and diversified cargo mix, which includes chemicals, intermodal containers, coal, automotive, and other merchandise. The current investor narrative centers on the company's ability to manage costs and drive volume growth to offset macroeconomic softness, as evidenced by recent quarterly earnings beats despite slight revenue misses, with attention focused on its operational efficiency and resilience in a potentially slowing industrial economy.…
CSX
CSX Corporation
$46.16
Related headlines
Investment Opinion: Should I buy CSX Today?
Rating & Thesis: CSX is rated a Hold. The core thesis is that while the company is a high-quality operator with a strong balance sheet and cash flow, its premium valuation and stagnant growth profile limit near-term upside, making the risk/reward balanced at current levels. The limited analyst data shows a cautious stance, with a recent downgrade highlighting this view.
Supporting Evidence: The Hold rating is supported by four key data points. First, valuation is full at a trailing PE of 23.39x, near its historical peak. Second, revenue growth is absent, with a -0.88% YoY decline in Q4. Third, profitability, while robust at a 20.5% net margin, is compressing from higher levels. Fourth, the stock trades at 95% of its 52-week high, suggesting most positive news is priced in. The forward PE of 21.03x offers only a modest discount, insufficient to compensate for the growth headwinds.
Risks & Conditions: The two biggest risks are a failure to reignite volume growth and a valuation derating. This Hold would upgrade to a Buy if the trailing PE compresses below 18x (offering a better entry point) or if quarterly revenue growth turns sustainably positive above 3%. It would downgrade to a Sell if revenue declines accelerate beyond -3% YoY or if the net margin falls below 18%. Relative to its own history and the current growth trajectory, the stock is overvalued.
Sign up to view all
CSX 12-Month Price Forecast
The AI assessment is neutral on CSX with medium confidence. The company's exceptional cash flow and profitability are undeniable strengths, but they are currently overshadowed by a full valuation and lack of growth. The stock's 41% annual run appears to have priced in much of the operational excellence, leaving little margin for error. The stance would upgrade to bullish on a meaningful pullback (below $40) that improves the valuation proposition, or on clear evidence of sustained volume and revenue acceleration. It would turn bearish if margin compression accelerates or if the stock breaks key technical support around $42.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on CSX Corporation's 12-month outlook, with a consensus price target around $60.01 and implied upside of +30.0% versus the current price.
Average Target
$60.01
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$37 - $60
Analyst target range
Analyst coverage for CSX appears limited in the provided dataset, with only 5 analysts cited for EPS estimates, and no explicit consensus price target, Buy/Hold/Sell distribution, or target range is available in the data fields. The lack of comprehensive analyst target data suggests coverage may be more concentrated among a few major firms, which is typical for large-cap industrials but can still lead to periods of high conviction-driven price moves. Recent institutional rating actions show a mix of reaffirmations, with a notable downgrade from Evercore ISI from 'Outperform' to 'In Line' in March 2026, potentially signaling a more cautious near-term outlook amidst the stock's strong run-up. The wide dispersion in estimated EPS for the next period, with a low of $2.72 and a high of $2.88, indicates some underlying uncertainty about the earnings trajectory, which aligns with the observed revenue softness and margin compression trends.
Bulls vs Bears: CSX Investment Factors
The investment debate for CSX centers on the tension between its high-quality, cash-generating business model and its premium valuation amid slowing fundamental growth. The bull case is supported by exceptional profitability, strong cash flow, and operational resilience, which have driven significant market outperformance. The bear case highlights concerning trends in revenue stagnation, margin compression, and a valuation that appears to have priced in a recovery. Currently, the bearish evidence on growth and valuation is more compelling, as the stock's 41% annual gain seems to have run ahead of the underlying fundamentals. The single most important factor is whether CSX can re-accelerate volume and revenue growth to justify its elevated PE multiple; failure to do so risks a painful valuation derating.
Bullish
- Strong Profitability & Cash Flow: CSX maintains robust profitability with a trailing net margin of 20.50% and generated $3.94 billion in TTM free cash flow. This strong cash generation, coupled with an ROE of 21.95%, funds shareholder returns and provides a buffer against economic softness.
- Operational Resilience & Cost Control: Recent earnings beats, despite slight revenue misses, highlight the company's ability to manage costs effectively. The Q4 2025 EBITDA margin of 43.8% demonstrates sustained operational efficiency, allowing the company to navigate volume challenges.
- Dominant Market Position & Network: As a Class I railroad with over 21,000 miles of track in the Eastern U.S., CSX possesses a significant competitive moat. Its diversified cargo mix, including chemicals (17% of revenue) and intermodal (16%), provides revenue stability.
- Strong Technical Momentum & Outperformance: The stock has significantly outperformed the market, with a 1-year price change of 41.53% versus the S&P 500's 24.99%. Trading at 95% of its 52-week high ($48.03), it reflects strong investor confidence and momentum.
Bearish
- Revenue Stagnation & Volume Pressure: Q4 2025 revenue of $3.51 billion declined 0.88% YoY, continuing a trend of sequential quarterly declines from $3.59B in Q3. This reflects broader industrial demand challenges and raises questions about near-term top-line growth.
- Margin Compression from Peak Levels: Profitability is under pressure, with the Q4 gross margin of 31.64% down significantly from the 38.69% high in mid-2024. The trailing net margin of 20.50% has also compressed from 26.02% in Q2 2024, indicating cyclical pressure on operating leverage.
- Premium Valuation with Limited Growth: CSX trades at a trailing PE of 23.39x, near the upper end of its 5-year historical range. This premium valuation, coupled with stagnant revenue, leaves little room for multiple expansion unless earnings accelerate meaningfully.
- Analyst Caution & Earnings Uncertainty: A notable analyst downgrade from Evercore ISI to 'In-Line' in March 2026 signals a more cautious outlook. Furthermore, a wide EPS estimate dispersion for the next period ($2.72 low to $2.88 high) indicates underlying uncertainty about the earnings trajectory.
CSX Technical Analysis
CSX is in a sustained uptrend, with a 1-year price change of 41.53% significantly outperforming the broader market. The stock's current price of $45.63 places it at approximately 95% of its 52-week high of $48.03, indicating it is trading near the top of its range and reflecting strong investor momentum, though it also suggests potential overextension. Recent momentum shows a slight deceleration, with a 1-month price change of -0.98%, which contrasts with the strong 3-month gain of 19.54%, signaling a potential consolidation or short-term pullback within the broader uptrend. The stock's beta of 1.22 indicates it is 22% more volatile than the market, which is relevant for risk assessment, especially given the recent pullback from the highs. Key technical levels are the 52-week high of $48.03 acting as immediate resistance and the 52-week low of $31.80 providing distant support; a decisive breakout above $48.03 would confirm the bullish trend's continuation, while a break below recent lows near $45 could signal a deeper correction.
Beta
1.22
1.22x market volatility
Max Drawdown
-12.2%
Largest decline past year
52-Week Range
$32-$48
Price range past year
Annual Return
+42.4%
Cumulative gain past year
| Period | CSX Return | S&P 500 |
|---|---|---|
| 1m | +1.4% | -1.6% |
| 3m | +16.7% | +11.7% |
| 6m | +25.5% | +6.3% |
| 1y | +42.4% | +22.2% |
| ytd | +27.3% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CSX Fundamental Analysis
Revenue growth has been stagnant to slightly negative recently, with Q4 2025 revenue of $3.51 billion representing a year-over-year decline of 0.88%, continuing a trend of sequential quarterly declines from $3.59 billion in Q3 and $3.57 billion in Q2. The merchandise segment, contributing $2.18 billion, remains the largest revenue driver, but overall volume trends are mixed, reflecting broader industrial demand challenges. Profitability remains robust, with the company posting a net income of $720 million in Q4 and a trailing net margin of 20.50%, though margins have compressed from the 26.02% net margin seen in Q2 2024, indicating some pressure from lower volumes and potentially higher costs. The gross margin of 31.64% in the latest quarter is down from the 38.69% high in mid-2024, highlighting the cyclical pressures on railroad operating leverage. The balance sheet is leveraged but manageable, with a debt-to-equity ratio of 1.47 and a current ratio of 0.81, indicating adequate but not strong short-term liquidity. The company generates substantial cash, with trailing twelve-month free cash flow of $3.94 billion and an ROE of 21.95%, demonstrating its ability to fund operations, dividends, and share buybacks internally despite the elevated debt load.
Quarterly Revenue
$3.5B
2025-12
Revenue YoY Growth
+0.00%
YoY Comparison
Gross Margin
+0.31%
Latest Quarter
Free Cash Flow
$3.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CSX Overvalued?
Given a positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. CSX trades at a trailing PE of 23.39x and a forward PE of 21.03x, with the forward multiple being lower, suggesting the market anticipates modest earnings growth. Compared to industry averages, CSX's trailing PE of 23.39x trades at a premium; while a direct industry average is not provided in the data, the forward PE of 21.03x and EV/EBITDA of 14.70x suggest a valuation that prices in the company's stable cash flows and market position. Historically, the stock's current trailing PE of 23.39x is above its own 5-year range, which has seen lows near 12.7x and highs above 25x, indicating it is trading near the upper end of its historical valuation band. This positioning near historical highs suggests the market has largely priced in a recovery and operational efficiency gains, leaving limited room for multiple expansion unless earnings accelerate meaningfully.
PE
23.5x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 13x~26x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
14.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: CSX faces financial risks from its elevated leverage, with a debt-to-equity ratio of 1.47, and weak short-term liquidity, indicated by a current ratio of 0.81. While free cash flow is strong, the company is exposed to margin pressure, as evidenced by the 700+ basis point contraction in gross margin from its mid-2024 peak to 31.64% in Q4 2025. Revenue concentration in cyclical segments like chemicals (17%) and coal (16%) creates earnings volatility, making the company dependent on a broad industrial recovery to drive volume growth and protect its 20.5% net margin.
Market & Competitive Risks: The primary market risk is valuation compression. Trading at a trailing PE of 23.39x, near its 5-year historical high, the stock is vulnerable to derating if earnings growth fails to materialize. Its beta of 1.22 indicates it is 22% more volatile than the market, amplifying downside during sector-wide selloffs. Competitive risks include long-term modal shift away from rail and potential regulatory headwinds. The recent analyst downgrade to 'In-Line' reflects growing market skepticism about near-term catalysts for multiple expansion.
Worst-Case Scenario: The worst-case scenario involves a deepening industrial recession leading to sustained volume declines, exacerbated by rising costs that compress margins further. This could trigger a wave of analyst downgrades and a valuation re-rating towards the lower end of its historical PE range, potentially around 15x. Coupled with a break of key technical support, this could see the stock retreat towards its 52-week low of $31.80. From the current price of $45.63, this scenario implies a realistic downside of approximately -30%.
FAQ
The key risks are: 1) Valuation Risk: The primary risk is a derating of its premium PE multiple (23.39x) if growth remains elusive. 2) Cyclical Demand Risk: Revenue stagnation and a 700+ bps gross margin decline from peak highlight sensitivity to industrial economic weakness. 3) Financial Risk: Elevated leverage with a debt-to-equity of 1.47 and weak liquidity (current ratio 0.81) could pressure the company in a downturn. 4) Competitive/Regulatory Risk: Long-term threats from modal shift and potential increased rail regulation.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $42 and $47, assuming stable industrial demand and earnings in line with the $2.78 average EPS estimate. The Bull Case (25% probability) targets $48 to $52 on a volume recovery and margin expansion. The Bear Case (15% probability) warns of a drop to $32-$38 on an economic slowdown and valuation compression. The base case is most likely, anchored by the assumption that CSX's strong cash flows will prevent a severe decline, but its high valuation will cap significant upside.
CSX stock appears overvalued relative to its current growth profile. It trades at a trailing PE of 23.39x, which is near the upper end of its own 5-year historical range. A forward PE of 21.03x suggests the market expects only modest earnings growth. Given the sequential revenue declines and margin compression, this premium multiple is not justified by fundamentals. The valuation implies the market is paying for stability and cash flow, but it is pricing in a recovery that has yet to materialize in the top line.
CSX is not an compelling buy at its current price of $45.63. While the company is a fundamentally strong operator with excellent cash flow, its valuation is full at a trailing PE of 23.39x, and revenue growth is stagnant (-0.88% YoY). The stock trades at 95% of its 52-week high, suggesting limited near-term upside. For a patient, long-term investor, it could be a good buy on a significant pullback towards the low $40s, which would improve the risk/reward profile. For others, it is a Hold.
CSX is far more suitable for a long-term investment horizon (3-5 years minimum) than for short-term trading. Its business model is tied to long-term economic cycles, and its value is derived from the durability of its network and cash flows. The stock's beta of 1.22 indicates above-market volatility, making it risky for short-term bets. Furthermore, the current valuation disconnect suggests it may take time for fundamentals to catch up to the price or for a better entry point to emerge. Income-focused investors can consider it for the dividend, but should be prepared for cyclical price swings.